SO
YMAB

STRS Ohio’s Y-mAbs Therapeutics YMAB Stock Holding History

STRS Ohio’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-62,400
Closed -$281K – 2298
2025
Q2 		$281K Buy
62,400
+19,000
+44% +$85.4K ﹤0.01% 1532
2025
Q1 		$192K Hold
43,400
– – ﹤0.01% 1522
2024
Q4 		$340K Hold
43,400
– – ﹤0.01% 1339
2024
Q3 		$571K Hold
43,400
– – ﹤0.01% 1174
2024
Q2 		$524K Buy
43,400
+8,300
+24% +$112K ﹤0.01% 1209
2024
Q1 		$570K Sell
35,100
-43,600
-55% -$588K ﹤0.01% 1165
2023
Q4 		$536K Sell
78,700
-10,300
-12% -$59.6K ﹤0.01% 1253
2023
Q3 		$485K Buy
89,000
+14,900
+20% +$86.8K ﹤0.01% 1279
2023
Q2 		$503K Sell
74,100
-74,700
-50% -$560K ﹤0.01% 1284
2023
Q1 		$745K Buy
148,800
+38,900
+35% +$159K ﹤0.01% 1068
2022
Q4 		$536K Buy
109,900
+80,800
+278% +$587K ﹤0.01% 1292
2022
Q3 		$419K Buy
29,100
+2,500
+9% +$41.4K ﹤0.01% 1391
2022
Q2 		$402K Buy
26,600
+1,500
+6% +$17.5K ﹤0.01% 1420
2022
Q1 		$298K Buy
+25,100
New +$258K ﹤0.01% 1606
2021
Q2 		– Sell
-15,200
Closed -$459K – 2448
2021
Q1 		$459K Buy
15,200
+1,400
+10% +$57.4K ﹤0.01% 1604
2020
Q4 		$683K Hold
13,800
– – ﹤0.01% 1294
2020
Q3 		$529K Sell
13,800
-3,200
-19% -$127K ﹤0.01% 1296
2020
Q2 		$734K Sell
17,000
-6,600
-28% -$250K ﹤0.01% 1055
2020
Q1 		$615K Hold
23,600
– – ﹤0.01% 986
2019
Q4 		$737K Buy
23,600
+1,500
+7% +$44.4K ﹤0.01% 1138
2019
Q3 		$575K Buy
22,100
+20,200
+1,063% +$516K ﹤0.01% 1163
2019
Q2 		$43K Hold
1,900
– – ﹤0.01% 1949
2019
Q1 		$49K Hold
1,900
– – ﹤0.01% 1892
2018
Q4 		$38K Buy
+1,900
New +$43.6K ﹤0.01% 1914

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

STRS Ohio's YMAB Position: Q3 2025 in Review

STRS Ohio sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 62,400 shares — an estimated $281K sold.

STRS Ohio first reported a position in YMAB in Q4 2018 and held it in 24 quarters. The position peaked at $745K in Q1 2023. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • STRS Ohio reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • STRS Ohio sold 62,400 Y-mAbs Therapeutics shares in Q3 2025, an estimated $281K.
  • STRS Ohio first reported a position in Y-mAbs Therapeutics in Q4 2018 and held it in 24 quarters.
  • STRS Ohio's Y-mAbs Therapeutics position peaked at $745K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on STRS Ohio's 13F filing for Q3 2025, filed 30 Oct 2025.